This article is about conflict between for-profit companies over who should get the blame for escalating prescription drug prices.
Nke a bụ a njem nleta arọ ebe otú ahịa nke ọgwụ ọjọọ ga-inflated, -atụ anya na-akwụ ụgwọ ụzọ n'elu nkezi obodo price.